A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy

Abstract Background This study aims to evaluate the effect of subcutaneous (SC) elamipretide dosing on exercise performance using the 6 min walk test (6MWT), patient‐reported outcomes measuring fatigue, functional assessments, and safety to guide the development of the Phase 3 trial. Methods MMPOWER...

Full description

Bibliographic Details
Main Authors: Amel Karaa, Richard Haas, Amy Goldstein, Jerry Vockley, Bruce H. Cohen
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Online Access:https://doi.org/10.1002/jcsm.12559